Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morgan, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morgan, J. P.

Amphetamine and Methamphetamine During the 1990s

John P. Morgan MD1
1 Medical Professor, City University of New York, New York, NY 10031

A 1981 review of toxicity and illicit use of amphetamine noted that governmental actions had diminished the diversion of pharmaceutical amphetamine and methamphetamine. Much of the illicit market prior to 1972 had been supplied by diversion of legitimately manufactured material, chiefly through careless (or even criminal) wholesaling. Following the reduced availability of diverted amphetamine, a number of events transpired. A market of fake "look-alike" products evolved. These were produced in formulations that resembled popular amphetamine products and that contained available over-the-counter stimulants, such as ephedrine and caffeine. Between 1980 and 1982, a very popular "triple product" appeared that contained caffeine, ephedrine, and phenylpropanolamine. The look-alike problem was diminished by a series of actions taken by the federal Food and Drug Administration in 1984 that outlawed the legal marketing of any such combinations.

Illicit synthesis and marketing of methamphetamine continues. Although distribution remains limited chiefly to southern California, it has clinical importance. While a volatile version of methamphetamine ("ice") has received wide exposure in the American media, its true clinical impact apparently remains limited.

Definitions and Terminology

Amphetamine refers to a unique chemical, for which there are a number of precise terms: methylphenethylamine, phenylisopropylamine, and 2-amino-1-phenylopropane. Use of the term "amphetamines" is careless; there is no basis for using the plural term.




This article has been cited by other articles:


Home page
Journal of Pharmacy PracticeHome page
J. A. Barone and K. M. Shermock JR
Designer Drugs of Abuse
Journal of Pharmacy Practice, August 1, 1997; 10(4): 292 - 300.
[Abstract] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics  Pediatrics in Review
Copyright © 1992 by the American Academy of Pediatrics.